Increased clearance explains lower plasma levels of tissue-type plasminogen activator by estradiol: Evidence for potently enhanced mannose receptor expression in mice

Blood

Volumn 94, Issue 4, 1999, Pages 1330-1336

  Lansink, Mirian ^b   Jong, Miek ^b   Bijsterbosch, Martin ^b   Bekkers, Marian ^b   Toet, Karin ^b   Havekes, Louis ^b   Emeis, Jef ^b   Kooistra, Teake ^a  

^a TNO   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; LOW DENSITY LIPOPROTEIN RECEPTOR; MANNOSE RECEPTOR; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ARTICLE; ESTROGEN BLOOD LEVEL; FIBRINOLYSIS; GENE EXPRESSION; HORMONE ACTION; MOUSE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEPTOR BINDING;

EID: 0033566924     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.4.1330.416k19_1330_1336     Document Type: Article

References (48)

1. Emeis JJ, Verheijen JH, Ronday HK, De Maat MPM, Brakman P: Progress in clinical fibrinolysis. Fibrinol Proteol 11:67, 1997
2. Lijnen HR, Collen D: Fibrinolytic agents: Mechanisms of activity and pharmacology. Thromb Haemost 74:387, 1995
3. Kooistra T, Schrauwen Y, Arts J, Emeis JJ: Regulation of endothelial cell t-PA synthesis and release. Int J Hematol 59:233, 1994
4. Sprengers ED, Kluft C: Plasminogen activator inhibitors. Blood 69:381, 1987
5. Noorman F, Rijken DC: Regulation of tissue-type plasminogen activator (t-PA) concentrations by clearance via the mannose receptor and other receptors. Fibrinol Proteol 11:173, 1997
6. Kooistra T, Lansink M, Emeis JJ: Stimulators of tissue-type plasminogen activator. Drugs Future 21:291, 1996
7. Chandler WL, Alessi MC, Aillaud MF, Henderson P, Vague P, Juhan-Vague I: Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: Relationship to elevated TPA antigen in patients with high PAI-1 activity levels. Circulation 96:761, 1997
8. Van Griensven JM, Huisman LG, Stuurman T, Dooijewaard G, Kroon R, Schoemaker RC, Kluft C, Cohen AF: Effects of increased liver blood flow on the kinetics and dynamics of recombinant tissue-type plasminogen activator. Clin Pharmacol Ther 60:504, 1996
9. Siegbahn A, Ruusuvaara L: Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers. Thromb Haemost 60:361, 1988
10. Eliasson M, Evrin PE, Lundblad D, Asplund K, Ranby M: Influence of gender, age and sampling time on plasma fibrinolytic variables and fibrinogen. A population study. Fibrinolysis 7:316, 1993
11. Gebara OC, Mittleman MA, Sutherland P, Lipinska DI, Matheney T, Xu P, Welty FK, Wilson PW, Levy D, Muller JE: Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. Circulation 91:1952, 1995
12. Gevers Leuven JA, Kluft C, Bertina RM, Hessel LW: Effects of two low-dose oral contraceptives on circulating components of the coagulation and fibrinolytic systems. J Lab Clin Med 109:631, 1987
13. Petersen KR, Sidelman J, Skouby SO, Jespersen J: Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women. Am J Obstet Gynecol 168:32, 1993
14. Van Kesteren PJM, Kooistra T, Lansink M, Van Kamp GJ, Asscheman H, Gooren LJG, Emeis JJ, Vischer UM, Stehouwer CDA: The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning. Thromb Haemost 79:1029, 1998
15. Kooistra T, Bosma PJ, Jespersen J, Kluft C: Studies on the mechanism of action of oral contraceptives with regard to fibrinolytic variables. Am J Obstet Gynecol 163:404, 1990
16. Barrett-Bergshoeff M, Noorman F, Bos R, Rijken DC: Monoclonal antibodies against the human mannose receptor that inhibit the binding of tissue-type plasminogen activator. Thromb Haemost 77:718, 1997
17. Emeis JJ, Hoekzema R, De Vos AF: Inhibiting interleukin-1 and tumor necrosis factor-alpha does not reduce induction of plasminogen activator inhibitor type-1 by endotoxin in rats in vivo. Blood 85:115, 1995
18. Herz J, Goldstein JL, Strickland DK, Ho YK, Brown MS: 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. J Biol Chem 266:21232, 1991
19. Warshawsky I, Bu G, Schwartz AL: Identification of domains on the 39-kDa protein that inhibit the binding of ligands to the low density lipoprotein receptor-related protein. J Biol Chem 268:22046, 1993
20. Ziere GJ, Van der Kaaden ME, Vogelezang CJM, Boers W, Bihain BE, Kuiper J, Kruijt JK, Van Berkel TJC: Blockade of the alpha 2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein on rat liver parenchymal cells by the 39-kDa receptor-associated protein leaves the interaction of beta-migrating very-low-density lipoprotein with the lipoprotein remnant receptor unaffected. Eur J Biochem 242:703, 1996
21. Willnow TE, Sheng Z, Ishibashi S, Herz J: Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. Science 264:1471, 1994
22. Herz J, Gerard RD: Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci USA 90:2812, 1993
23. Jong MC, Dahlmans VEH, Van Gorp PJP, Van Dijk KW, Breuer ML, Hofker MH, Havekes LM: In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway. J Clin Invest 98:2259, 1996
24. Nagelkerke JF, Barto KP, Van Berkel TJC: In vivo and in vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, Kupffer, and parenchymal cells. J Biol Chem 258:12221, 1983
25. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
26. Lansink M, Kooistra T: Stimulation of tissue-type plasminogen activator expression by retinoic acid in human endothelial cells requires retinoic acid receptor beta 2 induction. Blood 88:531, 1996
27. Herz J, Hamann U, Rogne S, Myklebost O, Gausepohl H, Stanley KK: Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J 7:4119, 1988
28. Harris N, Super M, Rits M, Chang G, Ezekowitz RAB: Characterization of the murine macrophage mannose receptor: Demonstration that the downregulation of receptor expression mediated by interferon-gamma occurs at the level of transcription. Blood 80:2363, 1992
29. Emeis JJ: Perfused rat hindlegs. A model to study plasminogen activator release. Thromb Res 30:195, 1983
30. Smith D, Gilbert M, Owen WG: Tissue plasminogen activator release in vivo in response to vasoactive agents. Blood 66:835, 1985
31. Biessen EA, Van Teijlingen LM, Vietsch H, Barrett-Bergshoeff MM, Bijsterbosch MK, Rijken DC, Van Berkel TJC, Kuiper J: Antagonists of the mannose receptor and the LDL receptor-related protein dramatically delay the clearance of tissue plasminogen activator. Circulation 95:46, 1997
32. Narita M, Bu G, Herz J, Schwartz AL: Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo. J Clin Invest 96:1164, 1995
33. Lund H, Takahashi K, Hamilton RL, Havel RJ: Lipoprotein binding and endosomal itinerary of the low density lipoprotein receptor-related protein in rat liver. Proc Natl Acad Sci USA 86:9318, 1989
34. Kuiper J, Otter M, Rijken DC, Van Berkel TJC: Characterization of the interaction in vivo of tissue-type plasminogen activator with liver cells. J Biol Chem 263:18220, 1988
35. Brommer EJ, Derkx FH, Schalekamp M, Dooijewaard G, Van de Klaauw MM: Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man. Thromb Haemost 59:404, 1988
36. Moestrup SK, Gliemann J, Pallesen G: Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res 269:375, 1992
37. Bu G, Warshawsky I, Schwartz AL: Cellular receptors for the plasminogen activators. Blood 83:3427, 1994
38. Noorman F, Barrett-Bergshoeff MM, Biessen EA, Van de Bilt E, Van Berkel TJ, Rijken DC: Cluster mannosides can inhibit mannose receptor-mediated tissue-type plasminogen activator degradation by both rat and human cells. Hepatology 26:1303, 1997
39. Shahar E, Folsom AR, Salomaa VV, Stinson VL, McGovern PG, Shimakawa T, Chambless LE, Wu KK: Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 93:1970, 1996
40. Quehenberger P, Kapiotis S, Pärtan C, Schneider B, Wenzel R, Gaiger A, Speiser W: Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells. Ann Hematol 67:33, 1993
41. Winkler UH, Schindler AE, Endrikat J, Dusterberg B: A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol. Contraception 53:75, 1996
42. Lombarde A, Goi GC, Marchesini S, Luigi C, Moro M, Tettamanti G: Influence of age and sex on five human plasma lysosomal enzymes assayed by automated procedures. Cli nChim Acta 113:141, 1981
43. Goi G, Bairati C, Roggi C, Maccarini L, Tettamanti G, Meloni C, Lombardo A: The lysosomal N-acetyl-beta-D-glucosaminidase (NAG) isoenzymes in plasma: Study of distribution in a general population by a simple routine chromatofocusing procedure. Clin Chim Acta 321:47, 1993
44. Chao Y, Windler EE, Chen GC, Havel RJ: Hepatic catabolism of rat and human lipoprotems of rats treated with 17 alpha-ethinyl estradiol. J Biol Chem 254:11360, 1979
45. Stahl PD, Ezekowitz RA: The mannose receptor is a pattern recognition receptor involved in host defense. Curr Opin Immunol 10:50, 1998
46. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA: Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925, 1996
47. Mosselman S, Polman J, Dijkema R: ERβ: Identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49, 1996
48. Cowley SM, Hoare S, Mosselman S, Parker MG: Estrogen receptors alpha and beta form heterodimers on DNA. J Biol Chem 272:19858, 1997